Volume 7, Number 1—February 2001
Active Bacterial Core Surveillance of the Emerging Infections Program Network
|Group A||Group B||Haemophilus||Neisseria||Streptococcus|
|Range by areaa||2.6 - 4.1||4.8 - 8.5||1.1 - 2.3||0.6 - 2.0||20.0-28.9|
|Case- fatality ratio in||12.2%||9.5%||13.9%||13.7%||9.3%|
|Projected U.S. cases||10,200||17,400||3,900||2,500||63,000|
|Projected U.S. deaths||1,300||1,700||500||400||6,100|
|Penicillin nonsuscep-tibilityb||0||0||- -||1.1%||25.0%|
aIncidence = cases per 100,000.
bNonsusceptible includes isolates classified as either intermediate or resistant to penicillin. Results reflect testing of group A streptococcal isolates from 1997 (n=183) and group B streptococcal isolates from 1997 and 1998 combined (n=188).
- Page created: March 16, 2011
- Page last updated: March 16, 2011
- Page last reviewed: March 16, 2011
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)